Press release
Arthritis Monoclonal Antibodies Market Set to Reach $83.76 Billion by 2029 with 7.7% Yearly Growth
Arthritis Monoclonal Antibodies Market Size
The market for arthritis monoclonal antibodies has seen substantial growth in recent years. It is set to expand from $58.09 billion in 2024 to $62.29 billion in 2025, at a compound annual growth rate (CAGR) of 7.2%. Key factors for this growth during the historic period include a surge in cases of arthritis, heightened awareness and acceptance of arthritis monoclonal antibodies, extended approval of these antibodies, government encouragement for research and development, and increased funding from pharmaceutical corporations.
Predictions indicate a robust expansion of the arthritis monoclonal antibodies market in the coming years. The market is projected to reach $83.76 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this growth throughout the predicted period include combination therapies, broadened indications, patient preferences, and enhanced healthcare expenditure. The projected period also points towards emerging trends such as biosimilars and biobetters, targeted treatments, homecare management, real-world proof, issues related to cost and accessibility, and advancements in medication delivery.
What Are the Forces Behind the Rapid Growth of the Arthritis Monoclonal Antibodies Market?
Arthritis' increasing global incidence is fuelling the expansion of the arthritis monoclonal antibody market. Data from the Global RA Network in 2021 shows that over 350 million people worldwide are living with arthritis, with osteoarthritis being the most prevalent type. This is followed by gout, fibromyalgia, and rheumatoid arthritis. As per Arthritis Australia, a charitable non-profit organisation based in Australia, in February 2024, the number of Australians suffering from arthritis is projected to rise from 4.11 million in 2025 to 5.39 million by 2040. This rising incidence of arthritis is the driving force behind the growth of the arthritis monoclonal antibody market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3449&type=smp
Who Are the Dominant Companies Influencing Arthritis Monoclonal Antibodies Market Trends?
Major companies operating in the arthritis monoclonal antibodies market include Johnson & Johnson, Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., AbbVie Inc., Amgen Inc., Genentech Inc., GlaxoSmithKline plc., AstraZeneca plc, Bristol Myers Squibb, Eli Lilly and Company, Thermo Fisher Scientific Inc., Sanofi SA, Daiichi Sankyo Company Ltd., Seattle Genetics, Teva Pharmaceutical Industries Ltd., Shanghai Junshi Biosciences Co. Ltd., GenScript Biotech Corporation, Sigma-Aldrich Co. LLC, AbGenomics Corp., ADC Therapeutics SA, Agensys Inc., Alexion Pharmaceuticals Inc., ALMAC Group Ltd., Ambrx Inc., Astellas Pharma Inc., Celgene Corporation, Celldex Therapeutics Inc., Boehringer Ingelheim International GmbH, Celltrion Inc., HanAll Biopharma Co. Ltd., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation, Regeneron Pharmaceuticals Inc., Samsung Bioepis Co. Ltd.
How Is the Arthritis Monoclonal Antibodies Market Evolving?
The growth of the arthritis monoclonal antibody market is largely governed by the advancement in therapeutic monoclonal antibody products. Compared to small molecules and peptides, monoclonal antibodies demonstrate greater efficacy in treating arthritis due to their target-specific nature and high disease treatment efficiency. Evidence of these enhanced treatment approaches is seen through the increasing introduction of monoclonal antibody drugs for arthritis.
What Are the Different Segmentations in the Arthritis Monoclonal Antibodies Market?
The arthritis monoclonal antibodies market covered in this report is segmented -
1) By Drug: Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima
2) By Application: Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Other Applications
3) By End-Use: Hospitals, Research Institutes, Other End-Users
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report
Which Region Is at the Forefront of the Arthritis Monoclonal Antibodies Market?
The countries covered in the arthritis monoclonal antibodies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
What Is Covered In The Arthritis Monoclonal Antibodies Global Market Report?
- Market Size Analysis: Analyze the Arthritis Monoclonal Antibodies Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Arthritis Monoclonal Antibodies Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Arthritis Monoclonal Antibodies Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Arthritis Monoclonal Antibodies Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3449
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Arthritis Monoclonal Antibodies Market Set to Reach $83.76 Billion by 2029 with 7.7% Yearly Growth here
News-ID: 3931466 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Arthritis
Infectious Arthritis (Septic Arthritis) Market Detailed Industry Report Analysis …
Introduction
Infectious arthritis, also known as septic arthritis, is a serious joint condition caused by bacterial, viral, or fungal infections that lead to rapid joint destruction if not treated promptly. The disease primarily affects large joints such as the knee and hip but can also impact smaller joints. It is considered a medical emergency requiring rapid diagnosis and treatment with antibiotics or antifungals, often combined with joint drainage or surgical intervention.
The…
Nooro Arthritis Hand Massager Reviews: Is the Nooro Arthritis Hand Massager Wort …
The Nooro Arthritis Hand Massager is a revolutionary device designed to offer relief to individuals suffering from hand pain, particularly those dealing with conditions such as arthritis, carpal tunnel syndrome, and repetitive strain injuries. As hand pain can significantly impact daily activities, from typing to gripping objects, finding an effective, non-invasive solution is crucial. The Nooro Arthritis Hand Massager provides a gentle yet effective remedy by combining advanced heat therapy…
Psoriatic Arthritis Treatment Market - Unleash the Power of Relief: Elevating Tr …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Psoriatic Arthritis Treatment Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Psoriatic Arthritis Treatment provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes…
Rheumatoid Arthritis Drug Market Rheumatoid Arthritis Clinical Pipeline Report 2 …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Antirheumatoids: Call of Rheumatoid Arthritis
1.1 Prologue towards Rheumatoid Arthritis
1.2 Obtainable Treatment for Rheumatoid Arthritis
Molecular Mechanism of Antirheumatoids
2.1 Purpose of DMARDs in Rheumatoid Arthritis
2.2 Role of Biological Agents in Rheumatoid Arthritis
2.2.1 TNF- Inhibitors
2.2.2 Interleukin -1 and IL-6 Blockers
Classification of Rheumatoid Arthritis Drugs
3.1…
Rheumatoid Arthritis Treatment Market
Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheumatoid arthritis needs to be addressed early to avoid expensive joint replacement surgery. While it can affect any joint, small joints in hand and feet tend to be affected the…
Worldwide Arthritis - EpiCast Report: Rheumatoid Arthritis - Epidemiology Foreca …
"EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2025" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.
Description-
** Summary
Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the bodys immune system attacks the lining of the joints, known as…
